Evidence map›Paper›PMID 41798084›Full record

ArticleTurkish journal of chemistry2026

Development and optimization of a novel spectroscopic method to monitor crystallization behavior of BCS-II drug.

Uditi Handa, Anuj Malik, Kumar Guarve

Abstract read
In one paragraph

Article in Turkish journal of chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Uditi HandaGuru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India.ORCID https://orcid.org/0000-0001-7205-3345
Anuj MalikDepartment of Pharmaceutics, MM College of Pharmacy, MM (DU), Mullana, Ambala, Haryana, India.ORCID https://orcid.org/0000-0003-3754-1364
Kumar GuarveGuru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India.ORCID https://orcid.org/0000-0002-7066-3438

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the crystallization behavior of dextromethorphan hydrobromide, a class II drug, to improve understanding of its supersaturation potential and formulation design. Conventional methods often lack the sensitivity or scalability needed for accurate detection of early nucleation events. To overcome these limitations, a novel process tracks real-time absorbance below turbidity levels to detect early molecular aggregation and phase separation. Crystallization kinetics of the drug was assessed at concentrations of 0.1, 0.2, and 0.3 mg/mL using three analytical techniques, namely, isothermal crystallization (baseline), ultraviolet (UV) absorbance (turbidity monitoring, UV-TM), and an optimized UV absorbance graphical method (UV-GM) (novel process). Induction times were recorded for each method, and statistical analysis was performed. In the descriptive statistics analysis, the one-sample test, and Pearson's correlation were applied to evaluate consistency, variance, and the strength of association (R

Indexed as

biopharmaceutical classification system (BCS)-II drugcrystallization kineticsnucleation measurementstatistical analysisSupersaturationUV absorbance graphical method

Identifiers

PMID41798084
PMCPMC12965788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.